A Mouse Model for Breast Cancer Induced by Amplification and Overexpression of the neu Promoter and Transgene (original) (raw)

• Shih C, Padhy LC, Murray M, Weinberg RA. (1981) Transforming genes of carcinomas and neuroblastomas introduced into mouse fibroblasts. Nature 290: 261–264.
  Article CAS PubMed Google Scholar
• King CR, Kraus MH, Aaronson SA. (1985) Amplification of a novel _v-erbB_-related gene in a human mammary carcinoma. Science 229: 974–976.
  Article CAS PubMed Google Scholar
• Coussens L, Yang-Feng TL, Liao YC, et al. (1985) Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene. Science 230: 1132–1139.
  Article CAS PubMed Google Scholar
• Semba K, Kamata N, Toyoshima K, Yamamoto T. (1985) A _v-erbB_-related protooncogene, c-erbB-2, is distinct from the c-erbB-1/epidermal growth factor-receptor gene and is amplified in a human salivary gland adenocarcinoma. Proc. Natl. Acad. Sci. U.S.A. 82: 6497–6501.
  Article CAS PubMed PubMed Central Google Scholar
• Zeillinger R, Kury F, Czerwenka K, et al. (1989) HER-2 amplification, steroid receptors and epidermal growth factor receptor in primary breast cancer. Oncogene 4: 109–114.
  PubMed CAS Google Scholar
• Prigent SA, Lemoine NR. (1992) The type 1 (EGFR-related) family of growth factor receptors and their ligands. Prog. Growth Factor Res. 4: 1–24.
  Article CAS PubMed Google Scholar
• Slamon DJ, Godolphin W, Jones LA, et al. (1989) Studies of the HER-2_/neu_ proto-oncogene in human breast and ovarian cancer. Science 244: 707–712.
  Article CAS PubMed Google Scholar
• Parkes HC, Lillycrop K, Howell A, Craig RK. (1990) C-erbB2 mRNA expression in human breast tumours: comparison with c_-erbB2_ DNA amplification and correlation with prognosis. Br. J. Cancer 61: 39–45.
  Article CAS PubMed PubMed Central Google Scholar
• Heintz NH, Leslie KO, Rogers LA, Howard PL. (1990) Amplification of the c-erb B-2 oncogene and prognosis of breast adenocarcinoma. Arch. Pathol. Lab. Med. 114: 160–163.
  PubMed CAS Google Scholar
• Tiwari RK, Borgen PI, Wong GY, Cordon CC, Osborne MP. (1992) HER-2/neu amplification and overexpression in primary human breast cancer is associated with early metastasis. Anticancer Res. 12: 419–425.
  PubMed CAS Google Scholar
• Makar A, Desmedt EJ, DePotter CT, Vanderheyden JD, Schatteman ES. (1990) Neu oncogene in breast cancer and its possible association with the risk of distant metastases. Acta Oncologica 29: 931–934.
  Article CAS PubMed Google Scholar
• Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL. (1987) Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235: 177–182.
  Article CAS PubMed Google Scholar
• Persons DL, Borelli KA, Hsu PH. (1997) Quantitation of HER-2/neu and c-myc gene amplification in breast carcinoma using fluorescence in situ hybridization. Mod. Pathol. 10: 720–727.
  PubMed CAS Google Scholar
• Berger MS, Locher GW, Saurer S, et al. (1988) Correlation of c-erbB-2 gene amplification and protein expression in human breast carcinoma with nodal status and nuclear grading. Cancer Res. 48: 1238–1243.
  PubMed CAS Google Scholar
• Hudziak RM, Schlessinger J, Ullrich A. (1987) Increased expression of the putative growth factor receptor p185HER2 causes transformation and tumorigenesis of NIH 3T3 cells. Proc. Natl. Acad. Sci. U.S.A. 84: 7159–7163.
  Article CAS PubMed PubMed Central Google Scholar
• Hung MC, Schechter AL, Chavray PY, Stern DF, Weinberg RA. (1986) Molecular cloning of the neu gene: absence of gross structural alteration in oncogenic alleles. Proc. Natl. Acad. Sci. U.S.A. 83: 261–264.
  Article CAS PubMed PubMed Central Google Scholar
• Di Marco E, Pierce JH, Knicley CL, Di Fiore PP. (1990) Transformation of NIH 3T3 cells by overexpression of the normal coding sequence of the rat neu gene. Mol. Cell Biol. 10: 3247–3252.
  Article PubMed PubMed Central Google Scholar
• Muller WJ, Sinn E, Pattengale PK, Wallace R, Leder P. (1988) Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene. Cell 54: 105–115.
  Article CAS PubMed Google Scholar
• Guy CT, Webster MA, Schaller M, Parsons TJ, Cardiff RD, Muller WJ. (1992) Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease. Proc. Natl. Acad. Sci. U.S.A. 89: 10578–10582.
  Article CAS PubMed PubMed Central Google Scholar
• White MR, Hung MC. (1992) Cloning and characterization of the mouse neu promoter. Oncogene 7: 677–683.
  PubMed CAS Google Scholar
• Cardiff RD, Muller WJ. (1993) Transgenic mouse models of mammary tumorigenesis. Cancer Surv. 16: 97–113.
  PubMed CAS Google Scholar
• Pittius CW, Sankaran L, Topper YJ, Henninghausen L. (1988) Comparison of the regulation of the whey acidic protein gene with that of a hybrid gene containing the whey acidic protein gene promoter in transgenic mice. Mol. Endocrinol. 2: 1027–1032.
  Article CAS PubMed Google Scholar
• Knepper JE, Medina D, Butel JS. (1986) Differential expression of endogenouse mouse mammary tumor virus genes during development of the BALB/c mammary gland. J. Virol. 59: 518–521.
  PubMed PubMed Central CAS Google Scholar
• Schroeder JA, Lee DC. (1998) Dynamic expression and activation of ERBB receptors in the developing mouse mammary gland. Cell Growth Differ. 9: 451–464.
  PubMed CAS Google Scholar
• Flanagan JG, Leder P. (1988) neu Protooncogene fused to an immunoglobulin heavy chain gene requires immunoglobulin light chain for cell surface expression and oncogenic transformation. Proc. Natl. Acad. Sci. U.S.A. 85: 8057–8061.
  Article CAS PubMed PubMed Central Google Scholar
• Dougall WC, Qian X, Peterson NC, Miller MJ, Samanta A, Green MI. (1994) The neu oncogene: signal transduction pathways, transformation mechanisms and evolving therapies. Oncogene 9: 2109–2123.
  PubMed CAS Google Scholar
• Sympson CJ, Talhouk RS, Alexander CM, et al. (1994) Targeted expression of stromelysin-1 in mammary gland provides evidence for a role of proteinases in branching morphogenesis and the requirement for an intact basement membrane for tissue-specific gene expression. J. Cell Biol. 125: 681–693.
  Article CAS PubMed Google Scholar
• Daniel CW, Silberstein GB. (1987) In: Neville MC, Daniels CW (eds.) The Mammary Gland Development, Regulation, and Function. Plenum Press, New York, N.Y., pp. 3–36.
• Borellini F, Oka T. (1989) Growth control and differentiation in mammary epithelial cells. Environ. Health Perspect. 80: 85–99.
  Article CAS PubMed PubMed Central Google Scholar
• Lee M, Kim H, Jeon D, et al. (1996) Iron metabolism-related genes and mitochondrial genes are induced during involution of mouse mammary gland. Biochem. Biophys. Res. Commun. 224: 164–168.
  Article CAS PubMed Google Scholar
• Teng C, Pentecost BT, Chen YH, Newbold RR, Eddy EM, McLachlan JA. (1989) Lactotransferrin gene expression in the mouse uterus and mammary gland. Endocrinology 124: 992–999.
  Article CAS PubMed Google Scholar
• Strange R, Li F, Saurer S, Burkhardt A, Fris RR. (1992) Apoptotic cell death and tissue remodelling during mouse mammary gland involution. Development 115: 49–58.
  PubMed CAS Google Scholar
• Ross JS, Fletcher JA. (1998) The HER-2/neu oncogene in breast cancer: prognostic factor, predictive factor, and target for therapy. Stem Cells 16: 413–428.
  Article CAS PubMed Google Scholar
• Revillion F, Bonneterre J, Peyrat JP. (1998) ERBB2 oncogene in human breast cancer and its clinical significance. Eur. J. Cancer 34: 791–808.
  Article CAS PubMed Google Scholar
• Kokai Y, Cohen JA, Drebin JA, Greene MI. (1987) Stage- and tissue-specific expression of the neu oncogene in rat development. Proc. Natl. Acad. Sci. U.S.A. 84: 8498–8501.
  Article CAS PubMed PubMed Central Google Scholar
• Press MF, Cordon CC, Slamon DJ. (1990) Expression of the HER-2/neu proto-oncogene in normal human adult and fetal tissues. Oncogene 5: 953–962.
  PubMed CAS Google Scholar
• MacMahon B, Cole P, Lin TM, et al. (1970) Age at first birth and breast cancer risk. Bull. World Health Organ. 43: 209–221.
  PubMed PubMed Central CAS Google Scholar
• Siegel PM, Dankort DL, Hardy WR, Muller WJ. (1994) Novel activating mutations in the neu proto-oncogene involved in induction of mammary tumors. Mol. Cell Biol. 14: 7068–7077.
  Article CAS PubMed PubMed Central Google Scholar